Browse resources

Topic: Immunization financing

Total results with these characteristics: 119

Page 4 of 5  
‹ prev.
1
2
3
4
5
next ›

New Decade of Vaccines

In December 2010, global health leaders committed to making the next 10 years the Decade of Vaccines - to ensure discovery, development, and delivery of lifesaving vaccines globally, especially to the poorest countries. This special series of …

Author: Horton R, ed.

Published: 2011

Pneumococcal AMC

This section on the GAVI Alliance's website provides information about the pilot pneumococcal Advance Market Commitment (AMC), which is an innovative funding mechanism. It incentivizes vaccine makers to produce suitable and affordable vaccines for …

Author: GAVI Alliance

Potential Cost-Effectiveness of Vaccination for Rotavirus Gastroenteritis in Eight Latin American and Caribbean Countries

Investigators developed a model using epidemiological evidence, country-specific cost estimates, and vaccine efficacy data to estimate the cost-effectiveness of rotavirus vaccination and determined that it would reduce health care expenses and …

Author: Rheingans R, Constenla D, Antil L, Innis B, Breuer T

Published: 2007

The Problems and Promise of Vaccine Markets in Developing Countries

This article, published in Health Affairs, discusses a number of promising and innovative approaches that are being explored to increase the incentives and reduce the risks of investing in vaccines for developing countries. These approaches aim …

Author: Batson A

Published: 2005

Procurement and Pricing of New Vaccines for Developing Countries

Several vaccines that have come to market, including the rotavirus, pneumococcal conjugate, and human papillomavirus vaccines, have the potential to bring large public health benefits to developing countries. This eight-page policy brief explains …

Author: International AIDS Vaccine Initiative

Published: 2008

Progress in Cervical Cancer Prevention: The CCA Report Card

This report assesses global readiness to fight cervical cancer using new approaches and new technologies, especially in regions where the disease is a common killer. It underscores the urgent need for the global community to prioritize cervical …

Author: Cervical Cancer Action

Published: 2012

Projected Health and Economic Impact of Rotavirus Vaccination in GAVI-Eligible Countries: 2011–2030

This article, published in Vaccine, projects the cost-effectiveness and health impact of rotavirus vaccines in countries eligible for support from the GAVI Alliance. The authors used a decision-analytic model to project the health outcomes and …

Author: Atherly DE, Lewis KDC, Tate J, Parashar UD, Rheingans RD

Published: 2012

Projected Health Benefits and Costs of Pneumococcal and Rotavirus Vaccination in Uganda

The authors of this article, published in Vaccine, determined the impact and cost-effectiveness of pneumococcal and rotavirus vaccination programs among children younge than five years of age in Uganda from the public health system perspective. They …

Author: Tate JE, Kisakye A, Mugyenyi P, Kizza D, Odiit A, Braka F

Published: 2011

Projected Impact and Cost-Effectiveness of a Rotavirus Vaccination Program in India, 2008

The authors of this article, published in Clinical Infectious Diseases, aimed to determine the potential impact and cost-effectiveness of a national rotavirus vaccination program in India. They compared the national rotavirus disease and cost burden …

Author: Esposito DH, Tate JE, Kang G, Parashar UD

Published: 2011

ProVac Pneumococcal e-Learning Course

This online course is a practical tool designed to aid policy makers, national-level managers of immunization programs and other experts in making evidence-based decisions regarding the introduction of conjugate pneumococcal vaccines into national …

Author: Pan American Health Organization

ProVac Rotavirus e-Learning Course

This online course is a practical tool designed to aid health care administrators in making evidence-based decisions regarding rotavirus vaccine introduction into national immunization programs. The module provides training on topics ranging from …

Author: Pan American Health Organization

Public Finance of Rotavirus Vaccination in India and Ethiopia: An Extended Cost-Effectiveness Analysis

This article, published in Vaccine, reports on a study that evaluated the potential impact of a publicly funded national rotavirus vaccination program in India and Ethiopia on reducing deaths and household costs due to rotavirus disease. The authors …

Author: Verguet S, Murphy S, Anderson B, Johansson KA, Glass R, Rheingans R

Published: 2013

Pull Mechanisms for Value-Added Technologies for Vaccines

Project Optimize, a collaboration between PATH and the World Health Organization, commissioned this white paper to examine the issues influencing vaccine producer willingness to advance, adopt, and commercialize value-added technologies for …

Author: PATH, World Health Organization

Published: 2009

R&D for Diarrhoeal Diseases

While preventive measures such as clean drinking water and sanitation can reduce the risk of infection from diarrheal diseases, research and development (R&D) of new tools is equally important, particularly for vaccines as they can prevent …

Author: Policy Cures

Published: 2013

Reduced Price on Rotavirus Vaccines: Enough to Facilitate Access Where Most Needed?

This article, published in the Bulletin of the World Health Organization, examines whether the reduced prices for rotavirus vaccine are affordable enough to facilitate access to the vaccine where it is most needed. The study points to the rotavirus …

Author: Madsen LB, Ustrup M, Fischer TK, Bygbjerg IC, Konradsen F

Published: 2012

Revised Procedure for WHO Prequalification of Vaccines

This web page provides an explanation and link to the revised procedure for assessing the acceptability of vaccines in order to verify that they meet the specifications of the relevant United Nations agency for procurement and that they are produced …

Author: World Health Organization

Published: 2013

RHO Cervical Cancer Library

This website is designed to provide easy access to science-based information for health program managers and decision-makers seeking to prevent cervical cancer in developing countries and low-resource settings. The wide range of materials appearing …

Author: PATH

The Right Shot: Extending the Reach of Affordable and Adapted Vaccines

Lack of information on both the price and the different product characteristics of vaccines limits countries’ ability to operate affordable and effective immunization programs. This report aims to remedy some of the existing knowledge gaps by …

Author: Médecins Sans Frontières

Published: 2012

Rotavirus Disease in Uzbekistan: Cost-Effectiveness of a New Vaccine

Investigators estimated the costs related to rotavirus disease in Uzbekistan and determined that a vaccine would be cost-effective, while also drastically reducing hospitalizations and deaths. This article was published in the journal Vaccine.

Author: Isakbaeva E, Musabaevc E, Antil L, et al.

Published: 2007

Rotavirus in Asia: Updates on Disease Burden, Genotypes, and Vaccine Introduction

This special edition of the journal Vaccine broadens understanding of rotavirus disease burden, which is responsible for almost half of acute diarrhea hospitalizations among Asian children under five. In addition to documenting rotavirus …

Author: Nelson AS, Widdowson MA, Kilgore PE, Steele D, Parashar U, eds.

Published: 2009

Rotavirus Vaccination: Cost-Effectiveness and Impact on Child Mortality in Developing Countries

This article, published in The Journal of Infectious Diseases, aimed to project the uptake, health impact, and cost-effectiveness of introducing rotavirus vaccination in GAVI-eligible countries. The authors used a demand forecast model to predict …

Author: Atherly D, Dreibelbis R, Parashar UD, Levin C, Wecker J, Rheingans RD

Published: 2009

Rotavirus Vaccine RIX4414 (Rotarix™): A Pharmacoeconomic Review of its Use in the Prevention of Rotavirus Gastroenteritis in Developing Countries

This article, published in Pharmacoeconomics, provides an overview of the clinical profile of rotavirus vaccine RIX4414 (Rotarix™) in the prevention of rotavirus gastroenteritis in developing countries, followed by a comprehensive review of …

Author: Plosker GL

Published: 2011

Some Vaccine Costs Are Hidden Below the Surface

This banner serves as the backdrop for a vaccine presentation game in the project Optimize traveling exhibit—an exhibit featuring supply chain innovations being developed and tested in different countries around the world. The banner …

Author: PATH, World Health Organization

Published: 2013

State of the World's Vaccines and Immunization, Third Edition

This report focuses on the major developments in vaccines and immunization since 2000. Part 1 examines the impact of immunization on efforts to meet the Millennium Development Goals. It looks at the development and use of vaccines and the …

Author: World Health Organization, United Nations Children's Fund, World Bank

Published: 2009

Staying the Course? Malaria Research and Development in a Time of Economic Uncertainty

This technical report from the Roll Back Malaria Partnership shines a spotlight on recent trends in investments in malaria research and development (R&D). The report follows up on a 2005 study by the Malaria R&D Alliance to establish a …

Author: PATH

Published: 2011

Page 4 of 5  
‹ prev.
1
2
3
4
5
next ›